Please read these important legal notices and disclosures
None of the information displayed on or downloadable from https://www.precize.in represents an offer to buy or sell or a solicitation of an offer to buy or sell any security, nor does it constitute an offer to provide investment advice or service. Registered representatives of precize do not (1) Advise any member on the merits or advisability of a particular investment or transaction, or (2) Assist in the determination of fair value of any security or investment, or (3) Provide legal, tax, or transactional advisory services.
Anglo French Drugs and Industries Unlisted Share Price Today
52-week range ₹2,263 to ₹2,666.
ISIN INE570E01016.
Anglo-French Drugs & Industries is an Indian pharmaceutical manufacturing company engaged in the production and marketing of pharmaceutical formulations and healthcare products. The company primarily focuses on branded generic medicines across therapeutic segments such as antibiotics, vitamins, gastrointestinal treatments, and other prescription drugs. Founded in 1923, the company has over a century of operating history in the Indian pharmaceutical sector and operates its manufacturing facili…
Anglo French Drugs and Industries
Anglo-French Drugs & Industries is an Indian pharmaceutical manufacturing company engaged in the production and marketing of pharmaceutical formulations and healthcare products. The company primarily focuses on branded generic medicines across therapeutic segments such as antibiotics, vitamins, gastrointestinal treatments, and other prescription drugs.
Founded in 1923, the company has over a century of operating history in the Indian pharmaceutical sector and operates its manufacturing facility in Bengaluru, Karnataka. Anglo-French Drugs distributes its products mainly in the domestic market through pharmaceutical distributors and healthcare professionals.
The company operates in the formulations segment, generating revenue primarily from the sale of finished dosage pharmaceutical products. While smaller in scale compared to large pharmaceutical companies, it maintains a diversified product portfolio and continues to operate in India’s highly competitive generic drug market.
